{"protocolSection":{"identificationModule":{"nctId":"NCT01798264","orgStudyIdInfo":{"id":"ITCA 650-CLP-01"},"organization":{"fullName":"Intarcia Therapeutics","class":"INDUSTRY"},"briefTitle":"Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes","officialTitle":"A Phase Ib, Randomized, Open-Label, Multi-Center, 4-Week Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITCA 650 in Subjects With Type 2 Diabetes Mellitus"},"statusModule":{"statusVerifiedDate":"2013-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-02"},"primaryCompletionDateStruct":{"date":"2009-05","type":"ACTUAL"},"completionDateStruct":{"date":"2009-05","type":"ACTUAL"},"studyFirstSubmitDate":"2013-02-20","studyFirstSubmitQcDate":"2013-02-22","studyFirstPostDateStruct":{"date":"2013-02-25","type":"ESTIMATED"},"resultsFirstSubmitDate":"2013-02-25","resultsFirstSubmitQcDate":"2013-04-05","resultsFirstPostDateStruct":{"date":"2013-05-17","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-04-05","lastUpdatePostDateStruct":{"date":"2013-05-17","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Intarcia Therapeutics","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus."},"conditionsModule":{"conditions":["Type 2 Diabetes"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":44,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"10 mcg./day","type":"EXPERIMENTAL","description":"ITCA 650 (exenatide in DUROS)","interventionNames":["Drug: ITCA 650 (exenatide in DUROS)"]},{"label":"20 mcg/day","type":"EXPERIMENTAL","description":"ITCA 650 (exenatide in DUROS)","interventionNames":["Drug: ITCA 650 (exenatide in DUROS)"]},{"label":"40 mcg/day","type":"EXPERIMENTAL","description":"ITCA 650 (exenatide in DUROS)","interventionNames":["Drug: ITCA 650 (exenatide in DUROS)"]},{"label":"80 mcg/day","type":"EXPERIMENTAL","description":"ITCA 650 (exenatide in DUROS)","interventionNames":["Drug: ITCA 650 (exenatide in DUROS)"]}],"interventions":[{"type":"DRUG","name":"ITCA 650 (exenatide in DUROS)","armGroupLabels":["10 mcg./day","20 mcg/day","40 mcg/day","80 mcg/day"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Subjects With Study Drug-Related Adverse Events","timeFrame":"4 weeks"}],"secondaryOutcomes":[{"measure":"To Characterize the Pharmacokinetic Profile of ITCA 650 in Subjects With Type 2 Diabetes Mellitus","description":"Change in HbA1c from baseline","timeFrame":"4 weeks"},{"measure":"Change in Fasting Plasma Glucose (FPG) 4 Weeks From Baseline","timeFrame":"4 weeks"},{"measure":"Change in Weight From Baseline to 4 Weeks","timeFrame":"4 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* type 2 diabetes \\>6 months\n* stable diet \\& exercise, metformin, TZD or met + TZD HbA1c \\>6.5% \\<10.0%\n\nExclusion Criteria:\n\n* prior treatment with exenatide\n* history of pancreatitis\n* history of medullary thyroid cancer or multiple endocrine neoplasia 2","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"city":"Miami Gardens","state":"Florida","zip":"33169","country":"United States","geoPoint":{"lat":25.94204,"lon":-80.2456}},{"facility":"Medpace Clinical Pharmacology Unit","city":"Cincinnati","state":"Ohio","zip":"45212","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"dGd Research","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}}]},"referencesModule":{"references":[{"pmid":"23578605","type":"DERIVED","citation":"Henry RR, Logan D, Alessi T, Baron MA. A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes. Clin Ther. 2013 May;35(5):634-645.e1. doi: 10.1016/j.clinthera.2013.03.011. Epub 2013 Apr 8."}]}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"Initiated February 2009 completed 15 May 2009","groups":[{"id":"FG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"FG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"FG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"FG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"11"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"7"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"4"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"BG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"BG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"BG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"BG004","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"44"}]}],"measures":[{"title":"Age Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"56.3","spread":"6.74"},{"groupId":"BG001","value":"57.2","spread":"6.10"},{"groupId":"BG002","value":"52.6","spread":"9.54"},{"groupId":"BG003","value":"56.5","spread":"4.84"},{"groupId":"BG004","value":"55.7","spread":"6.92"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"18"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"26"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"44"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Study Drug-Related Adverse Events","populationDescription":"Number of subjects reporting study drug-related adverse events","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"4 weeks","groups":[{"id":"OG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"11"}]}]}]},{"type":"SECONDARY","title":"To Characterize the Pharmacokinetic Profile of ITCA 650 in Subjects With Type 2 Diabetes Mellitus","description":"Change in HbA1c from baseline","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"percentage","timeFrame":"4 weeks","groups":[{"id":"OG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.39"},{"groupId":"OG001","value":"-0.6","spread":"0.31"},{"groupId":"OG002","value":"-0.5","spread":"0.31"},{"groupId":"OG003","value":"-0.7","spread":"0.36"}]}]}]},{"type":"SECONDARY","title":"Change in Fasting Plasma Glucose (FPG) 4 Weeks From Baseline","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"mg/dL","timeFrame":"4 weeks","groups":[{"id":"OG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.6","spread":"34.33"},{"groupId":"OG001","value":"-31.2","spread":"24.2"},{"groupId":"OG002","value":"-42.0","spread":"33.16"},{"groupId":"OG003","value":"-28.8","spread":"33.5"}]}]}]},{"type":"SECONDARY","title":"Change in Weight From Baseline to 4 Weeks","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"kg","timeFrame":"4 weeks","groups":[{"id":"OG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"},{"id":"OG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"0.91"},{"groupId":"OG001","value":"-0.3","spread":"1.51"},{"groupId":"OG002","value":"-1.1","spread":"1.6"},{"groupId":"OG003","value":"-3.1","spread":"2.13"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"4 weeks","eventGroups":[{"id":"EG000","title":"10 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)","seriousNumAffected":0,"seriousNumAtRisk":12,"otherNumAffected":12,"otherNumAtRisk":12},{"id":"EG001","title":"20 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)","seriousNumAffected":0,"seriousNumAtRisk":11,"otherNumAffected":11,"otherNumAtRisk":11},{"id":"EG002","title":"40 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)","seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":9,"otherNumAtRisk":10},{"id":"EG003","title":"80 Mcg/Day","description":"ITCA 650 (exenatide in DUROS)","seriousNumAffected":0,"seriousNumAtRisk":11,"otherNumAffected":11,"otherNumAtRisk":11}],"otherEvents":[{"term":"eye swelling","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (11.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"photophobia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":12},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":11},{"groupId":"EG002","numEvents":9,"numAffected":6,"numAtRisk":10},{"groupId":"EG003","numEvents":23,"numAffected":8,"numAtRisk":11}]},{"term":"vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":6,"numAffected":3,"numAtRisk":11},{"groupId":"EG002","numEvents":5,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":23,"numAffected":9,"numAtRisk":11}]},{"term":"dyspepsia","organSystem":"General disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":5,"numAffected":4,"numAtRisk":11}]},{"term":"diarrhea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":11}]},{"term":"eructation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":11}]},{"term":"abdominal disomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":11}]},{"term":"GERD","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":11}]},{"term":"early satiety","organSystem":"General disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":11}]},{"term":"chills","organSystem":"General disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"feeling hot","organSystem":"General disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"incision site erythema","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":6,"numAffected":4,"numAtRisk":12},{"groupId":"EG001","numEvents":9,"numAffected":6,"numAtRisk":11},{"groupId":"EG002","numEvents":16,"numAffected":6,"numAtRisk":10},{"groupId":"EG003","numEvents":11,"numAffected":5,"numAtRisk":11}]},{"term":"incision site complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":8,"numAffected":6,"numAtRisk":12},{"groupId":"EG001","numEvents":8,"numAffected":7,"numAtRisk":11},{"groupId":"EG002","numEvents":16,"numAffected":7,"numAtRisk":10},{"groupId":"EG003","numEvents":8,"numAffected":5,"numAtRisk":11}]},{"term":"incision site hemmorhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":12},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":11},{"groupId":"EG002","numEvents":4,"numAffected":2,"numAtRisk":10},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":11}]},{"term":"incision site pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":12},{"groupId":"EG001","numEvents":3,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":10},{"groupId":"EG003","numEvents":6,"numAffected":5,"numAtRisk":11}]},{"term":"incision site blister","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":6,"numAffected":4,"numAtRisk":10},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":11}]},{"term":"incision site edema","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":12},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":11}]},{"term":"decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":12},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":11},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":10},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":11}]},{"term":"hyperlipasaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":11}]},{"term":"hyperamylasemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"hypoglycemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":11}]},{"term":"arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":11}]},{"term":"headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":12},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":11},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG003","numEvents":5,"numAffected":2,"numAtRisk":11}]},{"term":"dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":11}]},{"term":"paresthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":11}]},{"term":"dizziness extertional","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"lethargy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"syncope vasovagal","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"libido decreased","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"vulvovaginal dryness","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"hyperhidrosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]},{"term":"orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (11.0)","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":12},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":11},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":11}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"GT60","restrictiveAgreement":true},"pointOfContact":{"title":"Michelle Braon","organization":"Intarcia","phone":"510-782-7800"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-10-09"},"conditionBrowseModule":{"meshes":[{"id":"D003924","term":"Diabetes Mellitus, Type 2"}],"ancestors":[{"id":"D003920","term":"Diabetes Mellitus"},{"id":"D044882","term":"Glucose Metabolism Disorders"},{"id":"D008659","term":"Metabolic Diseases"},{"id":"D009750","term":"Nutritional and Metabolic Diseases"},{"id":"D004700","term":"Endocrine System Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077270","term":"Exenatide"}],"ancestors":[{"id":"D010455","term":"Peptides"},{"id":"D000602","term":"Amino Acids, Peptides, and Proteins"},{"id":"D014688","term":"Venoms"},{"id":"D045424","term":"Complex Mixtures"},{"id":"D014118","term":"Toxins, Biological"},{"id":"D001685","term":"Biological Factors"}]}},"hasResults":true}